Citius Oncology Inc.

0.65
-0.01 (-0.76%)
At close: Mar 28, 2025, 3:58 PM

Citius Oncology Balance Sheet Statement

Year FY24 FY23 FY22
Cash & Equivalents 112.00 n/a n/a
Short-Term Investments n/a n/a n/a
Long-Term Investments n/a n/a n/a
Other Long-Term Assets n/a n/a n/a
Receivables n/a n/a n/a
Inventory 8.27M n/a n/a
Other Current Assets 2.7M 7.73M 2.69M
Total Current Assets 10.97M 7.73M 2.69M
Property-Plant & Equipment n/a n/a n/a
Goodwill & Intangibles 73.4M 40M 40M
Total Long-Term Assets 73.4M 40M 40M
Total Assets 84.37M 47.73M 42.69M
Account Payables 3.71M 1.29M 92.31K
Deferred Revenue n/a n/a n/a
Short-Term Debt n/a n/a n/a
Other Current Liabilities 28.99M 19.76M 5.75M
Total Current Liabilities 32.7M 21.05M 5.85M
Long-Term Debt 3.8M n/a n/a
Other Long-Term Liabilities -1 n/a n/a
Total Long-Term Liabilities 5.53M 1.15M 576K
Total Liabilities 38.23M 22.2M 6.42M
Total Debt 3.8M n/a n/a
Common Stock 7.16K 167.00 242.00
Retained Earnings -39.28M -18.13M -5.43M
Comprehensive Income n/a n/a n/a
Shareholders Equity 46.14M 25.54M 36.27M
Total Investments n/a n/a n/a